Video

Newly Diagnosed with Cancer? Remember You’re 'Not a Statistic'

It's easy to get lost in the statistics of survivorship, but it's important for newly diagnosed patients with cancer to remember that they are not a statistic.

After being diagnosed with stage 1 triple-negative breast cancer (TNBC) in 2011, and stage 4 metastatic TNBC in 2016, Janice Cowden has learned firsthand that she is not a statistic – and she wants others who may be in a similar situation to know this, too.

In a recent interview with CURE®, Cowden and her husband and caregiver, Rex, spoke about how the facts and figures about survival rates in some cancer types can frighten newly diagnosed individuals, and how Janice made a habit of avoiding them, focusing instead on living in the present day.

“Our cancers are as unique as we are as individuals,” she says. “I think it's important to not look at the statistics and to not just assume that you are that statistic and that you're going to fit in those parameters of those statistics.”

“I realized that what I had to do to make each day good and livable was to plan to live that day.”

Transcription:

I think for me, what I have learned that I think I would share with someone who's newly diagnosed, regardless of their receptor type is that we're not a statistic. And our cancers are as unique as we are as individuals, our response to treatment is also as unique. So, I think it's important to not look at the statistics and to not just assume that you are that statistic and that you're going to fit in those parameters of those statistics.

I'm very fortunate. My oncologists never put a calendar date on me (or my survival). They, neither one of them, have ever said anything about a statistical prognosis for me. First of all, I think they realized that I read and research a lot, and they know that I can read that for myself. But there are so many people, especially newly diagnosed, that I think they automatically assume the worst. They plan to die, rather than planning to live.

And I think for the most part, once I reached a level of, I'm going to call it acceptance with this disease – and that came within the first six to 12 months after being diagnosed – I realized that what I had to do to make each day good and livable was to plan to live that day.

You know, I'm not dead yet. I'm probably not going to die tomorrow, or least not from this disease. And so, I think it's important to wake up and realize that each day is a gift.

For more news on cancer updates, research and education, don’t forget to subscribe to CURE®’s newsletters here.

Newsletter

Stay up to date on cancer updates, research and education

Related Videos
Image of man with text.
An expert highlights the impact of anemia in myelofibrosis and presented Ojjaara as a possible treatment to reduce transfusions and improve outcomes.
After ovarian cancer surgery, Mary Barbera spent three months in rehab before finally returning home, a milestone that marked her emotional recovery.
Terry Gillespie said the hardest parts of her cancer journey were the isolation, the impact of chemotherapy, and how unprepared she felt despite good guidance.
Dr. Erika Hamilton says social media and professional guidelines help patients stay informed about fast-changing breast cancer treatments and advances.
Outpatient CAR T-cell therapy has reduced hospital stays by two-thirds while maintaining safety for those with blood cancers, according to Dr. Olalekan Oluwole.
Dr. Masey Ross explains how biomarker testing, patient history, and quality-of-life concerns guide treatment decisions in metastatic breast cancer.
Dr. Paolo Tarantino shares how antibody-drug conjugates deliver more targeted chemo, and how the treatment lasts longer in the body vs traditional therapy.
Image of women with text.
The inMIND trial led to the FDA approval of Monjuvi with Revlimid and Rituxan for relapsed follicular lymphoma, showing benefits across diverse patients.
Related Content